TLPH

TALPHERA, INC.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001427925
$0.8156 -4.05% $43.9M
Insider Buying Cluster (4 insiders)5 New Institutional Positions
Vol
Market Cap$43.9M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders6 funds
Inst. Value$1.1M
Inst. Activity5 buys / 0 sells
Insider Activity5B / 0S
Insider Net $$304.0K
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001427925·Prev Close $0.8500

Recent Activity

May 20, 2026 Insider
Aslam Shakil sold 4,518 shares
Chief Medical Officer @ $0.8240 ($3.7K)
May 18, 2026 earnings_calendar
TLPH Q1 2026 Earnings Scheduled — 2026-05-18
Apr 2, 2026 Insider
ASADORIAN RAFFI sold 2,444 shares
Chief Financial Officer @ $0.7223 ($1.8K)
Apr 2, 2026 Insider
Aslam Shakil sold 2,118 shares
Chief Medical Officer @ $0.7223 ($1.5K)
Inst.
VANGUARD GROUP INC — DOUBLED
663,677 shares ($756.6K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
257,380 shares ($293.4K)

Price Targets

$3.17 +288.3% upside Strong Buy
Current $0.8156 Low $3.00 Median $3.00 High $3.50 3 analysts
$3.00 $3.50

Analyst Ratings

Strong Buy88% buy · 8 analysts
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Apr 30, 2026 WestPark Capital INITIATE Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.07 ▲ +18.8% $-0.07 — $-0.06 38% YoY 2
Next Q $-0.07 ▲ +22.2% $-0.07 — $-0.07 48% YoY 2
Current FY $-0.26 ▲ +27.1% $-0.26 — $-0.25 25% YoY 2
Next FY $-0.27 ▲ +3.6% $-0.29 — $-0.25 -6% YoY 2

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$756.6KDOUBLED
RENAISSANCE TECHNOLOGIES LLC$293.4KDOUBLED
TWO SIGMA INVESTMENTS, LP$28.0KNEW
WELLS FARGO & COMPANY/MN$1.1KDOUBLED
BANK OF AMERICA CORP$382.00ADD

Recent Insider Trades

DateInsiderTypeValue
May 20, 2026Aslam ShakilF$3.7K
Apr 2, 2026ASADORIAN RAFFIF$1.8K
Apr 2, 2026Aslam ShakilF$1.5K
Apr 2, 2026Angotti VincentF$7.2K
Apr 2, 2026Dasu BadriF$1.8K
6 institutional holders with $1.1M total value (946,973 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, TWO. Net buying activity: 5 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC663,677$756.6K70.1%DOUBLED +131.9%
2RENAISSANCE TECHNOLOGIES LLC257,380$293.4K27.2%DOUBLED +412.6%
3TWO SIGMA INVESTMENTS, LP24,588$28.0K2.6%NEW
4WELLS FARGO & COMPANY/MN983$1.1K0.1%DOUBLED +103.5%
5BANK OF AMERICA CORP /DE/335$382.000.0%ADD +90.3%
6MORGAN STANLEY10$11.000.0%NEAR_EXIT -99.1%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
VANGUARD GROUP INCDOUBLED286,229663,677+131.9%$756.6K2025-Q4
RENAISSANCE TECHNOLOGIES LLCDOUBLED50,214257,380+412.6%$293.4K2025-Q4
TWO SIGMA INVESTMENTS, LPNEW24,588$28.0K2025-Q4
WELLS FARGO & COMPANY/MNDOUBLED483983+103.5%$1.1K2025-Q4
BANK OF AMERICA CORP /DE/ADD176335+90.3%$382.002025-Q4
VANGUARD GROUP INCDOUBLED81,358286,229+251.8%$256.7K2025-Q3
RENAISSANCE TECHNOLOGIES LLCDOUBLED22,52650,214+122.9%$44.9K2025-Q3
UBS Group AGDOUBLED2227,650+125581.8%$24.7K2025-Q3
VANGUARD GROUP INCTRIM237,53281,358-65.7%$38.6K2025-Q2
RENAISSANCE TECHNOLOGIES LLCADD12,10022,526+86.2%$10.4K2025-Q2
WELLS FARGO & COMPANY/MNTRIM758483-36.3%$222.002025-Q2
BANK OF AMERICA CORP /DE/ADD145193+33.1%$89.002025-Q2
MORGAN STANLEYNEAR_EXIT1,07810-99.1%$5.002025-Q2
RENAISSANCE TECHNOLOGIES LLCTRIM19,64312,100-38.4%$6.0K2025-Q1
CITADEL ADVISORS LLCNEAR_EXIT55,34912,000-78.3%$5.9K2025-Q1
MORGAN STANLEYDOUBLED4511,078+139.0%$534.002025-Q1
CITADEL ADVISORS LLCNEW55,349$29.0K2024-Q4
RENAISSANCE TECHNOLOGIES LLCNEW19,643$10.3K2024-Q4
MORGAN STANLEYDOUBLED202451+123.3%$236.002024-Q4
UBS Group AGNEAR_EXIT43,61822-99.9%$12.002024-Q4
MORGAN STANLEYNEAR_EXIT1,167202-82.7%$173.002024-Q3
5 unique insiders with 5 transactions. Net insider value: $304.0K ($304.0K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 20, 2026Aslam ShakilChief Medical OfficerF4,518$0.8240$3.7K
Apr 2, 2026ASADORIAN RAFFIChief Financial OfficerF2,444$0.7223$1.8K
Apr 2, 2026Aslam ShakilChief Medical OfficerF2,118$0.7223$1.5K
Apr 2, 2026Angotti Vincent J.CHIEF EXECUTIVE OFFICERF9,938$0.7223$7.2K
Apr 2, 2026Dasu Badri NChief Engineering OfficerF2,444$0.7223$1.8K
Mar 13, 2026Nantahala Capital Management, LLC10%+ OwnerA4,266,211$0.5850$2.5M
Mar 13, 2026Angotti Vincent J.CHIEF EXECUTIVE OFFICERBUY213,310$0.5860$125.0K
Feb 14, 2026Angotti Vincent J.CHIEF EXECUTIVE OFFICERF9,559$0.7934$7.6K
Feb 14, 2026Dasu Badri NChief Engineering OfficerF2,346$0.7934$1.9K
Feb 14, 2026ASADORIAN RAFFIChief Financial OfficerF2,933$0.7934$2.3K
Feb 12, 2026Angotti Vincent J.CHIEF EXECUTIVE OFFICERBUY105,364$0.8123$85.6K
Feb 12, 2026Angotti Vincent J.CHIEF EXECUTIVE OFFICERA594,000$0.00$0.00
Feb 12, 2026Aslam ShakilChief Medical OfficerBUY35,000$0.8123$28.4K
Feb 12, 2026Aslam ShakilChief Medical OfficerA205,000$0.00$0.00
Feb 12, 2026Dasu Badri NChief Engineering OfficerBUY35,000$0.8123$28.4K
Feb 12, 2026Dasu Badri NChief Engineering OfficerA200,000$0.00$0.00
Feb 12, 2026ASADORIAN RAFFIChief Financial OfficerBUY45,000$0.8123$36.6K
Feb 12, 2026ASADORIAN RAFFIChief Financial OfficerA260,000$0.00$0.00
Feb 10, 2026Angotti Vincent J.CHIEF EXECUTIVE OFFICERF3,179$0.8361$2.7K
Feb 10, 2026Dasu Badri NChief Engineering OfficerF781$0.8361$652.99
Feb 10, 2026ASADORIAN RAFFIChief Financial OfficerF958$0.8361$800.98

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$3.17 mean target +288.3% upside Strong Buy (1.33)
$3.00 Low $3.50 High
MetricValue
Current Price$0.8156
Target Low$3.00
Target Mean$3.17
Target Median$3.00
Target High$3.50
# Analysts3
RecommendationStrong Buy (1.33)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.07 $-0.07 $-0.06 37.8% +18.8% 1↑ 0↓ $0.0B 0.0% 2
Next Q
2026-09-30
$-0.07 $-0.07 $-0.07 47.5% +22.2% 0↑ 1↓ $0.0B -100.0% 2
Current FY
2026-12-31
$-0.26 $-0.26 $-0.25 25.0% +27.1% $0.0B -100.0% 2
Next FY
2027-12-31
$-0.27 $-0.29 $-0.25 -5.9% +3.6% 0↑ 1↓ $0.0B 0.0% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.065
7d ago$-0.060-0.005
30d ago$-0.080+0.015
60d ago$-0.080+0.015
90d ago$-0.090+0.025
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Apr 30, 2026 WestPark Capital INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262510088%
May 1, 20262510088%
Apr 1, 20262510088%
Mar 1, 20262510088%
Feb 1, 20262510088%
Jan 1, 20262510088%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 18, 2026
earnings_calendar
TLPH Q1 2026 Earnings Scheduled — 2026-05-18
May 13, 2026
earnings_calendar
TLPH Q1 2026 Earnings Scheduled — 2026-05-13
Mar 5, 2026
earnings_calendar
TLPH Q4 2025 Earnings After Market Close — 2026-03-05